Synthesis, Bioapplications, and Toxicity Evaluation of Chitosan-Based Nanoparticles.
Author | Rizeq, Balsam R |
Author | Younes, Nadin N |
Author | Rasool, Kashif |
Author | Nasrallah, Gheyath K |
Available date | 2019-11-24T05:40:59Z |
Publication Date | 2019-11-01 |
Publication Name | International Journal Of Molecular Sciences |
Identifier | http://dx.doi.org/10.3390/ijms20225776 |
Citation | Rizeq, B.R.; Younes, N.N.; Rasool, K.; Nasrallah, G.K. Synthesis, Bioapplications, and Toxicity Evaluation of Chitosan-Based Nanoparticles. Int. J. Mol. Sci. 2019, 20, 5776. |
Identifier | Article # 5776 |
Abstract | The development of advanced nanomaterials and technologies is essential in biomedical engineering to improve the quality of life. Chitosan-based nanomaterials are on the forefront and attract wide interest due to their versatile physicochemical characteristics such as biodegradability, biocompatibility, and non-toxicity, which play a promising role in biological applications. Chitosan and its derivatives are employed in several applications including pharmaceuticals and biomedical engineering. This article presents a comprehensive overview of recent advances in chitosan derivatives and nanoparticle synthesis, as well as emerging applications in medicine, tissue engineering, drug delivery, gene therapy, and cancer therapy. In addition to the applications, we critically review the main concerns and mitigation strategies related to chitosan bactericidal properties, toxicity/safety using tissue cultures and animal models, and also their potential environmental impact. At the end of this review, we also provide some of future directions and conclusions that are important for expanding the field of biomedical applications of the chitosan nanoparticles. |
Language | en |
Publisher | MDPI |
Subject | Chitosan biomedical nanoparticles pharmaceuticals toxicity |
Type | Article |
Issue Number | 22 |
Volume Number | 20 |
Files in this item
This item appears in the following Collection(s)
-
Biomedical Sciences [738 items ]